Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation.
Louisa AshbyLydia ChanChristine WinterbournSee-Tarn WoonPaula KeatingRaoul HellerRohan AmeratungaIgnatius ChuaKuang-Chih HsiaoPublished in: Clinical & translational immunology (2024)
DA lesions, emphasising the need to tailor clinical management according to patients' disease phenotype and severity.